Moderate Hepatic Impairment
10 clinical trials · Condition
◉ Watch Moderate Hepatic Impairment
| Record | Firm | Date |
|---|---|---|
| A Study of Belzutifan (MK-6482) in Participants With Hepatic Impairment (MK-6482-020) (NCT04995484) | Merck Sharp & Dohme LLC | 2022-06-24 |
| A Study to Learn About the Study Medicine (Called Lorlatinib) in People With Liver Dysfunction (NCT05224609) | Pfizer | 2022-04-28 |
| Nitazoxanide Pharmacokinetic Parameters in Hepatic Impaired Patients (NCT05116826) | Genfit | 2021-11-05 |
| Pharmacokinetics of KBP-5074 in Patients With Moderate Hepatic Impairment (NCT04534699) | KBP Biosciences | 2020-08-27 |
| Study of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy Participants (NCT04223635) | Daiichi Sankyo | 2020-01-07 |
| A Study to Evaluate the Effect of IV Doses of Rivipansel in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function (NCT02871570) | GlycoMimetics Incorporated | 2016-09-01 |
| A Study of TMC207 in Patients With Moderately Impaired Hepatic Function (NCT01012284) | Tibotec BVBA | 2010-01-01 |
Track Moderate Hepatic Impairment automatically
Every clearance here is in the API, with alerts when new ones post.